2004
DOI: 10.1016/j.jns.2004.03.032
|View full text |Cite
|
Sign up to set email alerts
|

Evidence of axonal damage in human acute demyelinating diseases

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

2
19
0
1

Year Published

2005
2005
2020
2020

Publication Types

Select...
5
4
1

Relationship

0
10

Authors

Journals

citations
Cited by 37 publications
(22 citation statements)
references
References 17 publications
2
19
0
1
Order By: Relevance
“…Comparable white matter infiltrates of IL-21 + cells in MS were also observed in SSPE and HSE, suggesting a similar role of IL-21 in these neuro-inflammatory CNS diseases (Figure 3). In intriguing contrast, IL-21 + inflammatory cells were unexpectedly rare in ADEM, an acute monophasic neuro-inflammatory demyelinating disease 31 . This difference suggests that IL-21 is involved in the maintenance of chronic more than acute inflammation in the brain 32 and also in psoriatic skin 33 .…”
Section: Discussionmentioning
confidence: 96%
“…Comparable white matter infiltrates of IL-21 + cells in MS were also observed in SSPE and HSE, suggesting a similar role of IL-21 in these neuro-inflammatory CNS diseases (Figure 3). In intriguing contrast, IL-21 + inflammatory cells were unexpectedly rare in ADEM, an acute monophasic neuro-inflammatory demyelinating disease 31 . This difference suggests that IL-21 is involved in the maintenance of chronic more than acute inflammation in the brain 32 and also in psoriatic skin 33 .…”
Section: Discussionmentioning
confidence: 96%
“…Although DEM is typically described as white matter demyelination with relative preservation of axons, axonal damage has been identified in the brain of some patients [119,120].…”
Section: Immunopathogenesismentioning
confidence: 99%
“…While demyelination may be considered the hallmark of MS pathology, axonal damage is hypothesized to be the histologic substrate for disability (Trapp et al, 1998). Axonal loss can occur early in active disease (Ferguson et al, 1997; Ghosh et al, 2004) and is commonly observed later in the disease subtypes of primary progressive MS (PPMS) and secondary progressive MS (SPMS) (Tallantyre et al, 2009). …”
Section: Introductionmentioning
confidence: 99%